$497 Million is the total value of TANG CAPITAL MANAGEMENT LLC's 29 reported holdings in Q4 2021. The portfolio turnover from Q3 2021 to Q4 2021 was 65.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| ANAB | ANAPTYSBIO INC | $91,347,000 | +28.1% | 2,628,678 | 0.0% | 18.37% | +24.1% | |
| HRTX | Sell | HERON THERAPEUTICS INC | $71,058,000 | -15.9% | 7,782,928 | -1.6% | 14.29% | -18.6% |
| RCKT | ROCKET PHARMACEUTICALS INC | $55,269,000 | -27.0% | 2,531,800 | 0.0% | 11.12% | -29.2% | |
| LJPC | Sell | LA JOLLA PHARMACEUTICAL CO | $44,677,000 | +11.4% | 9,607,934 | -4.4% | 8.98% | +7.9% |
| ITOS | Buy | ITEOS THERAPEUTICS INC | $43,650,000 | +79.6% | 937,500 | +4.2% | 8.78% | +74.0% |
| CCXI | CHEMOCENTRYX INC | $18,205,000 | +112.9% | 500,000 | 0.0% | 3.66% | +106.3% | |
| ODT | Sell | ODONATE THERAPEUTICS INC | $17,236,000 | -61.8% | 12,767,435 | -17.7% | 3.47% | -63.0% |
| ALT | ALTIMMUNE INC | $14,656,000 | -19.0% | 1,600,000 | 0.0% | 2.95% | -21.5% | |
| ANIP | New | ANI PHARMACEUTICALS INC | $13,824,000 | – | 300,000 | +100.0% | 2.78% | – |
| ALLK | New | ALLAKOS INC | $12,956,000 | – | 1,323,393 | +100.0% | 2.61% | – |
| IMGN | New | IMMUNOGEN INC | $11,130,000 | – | 1,500,000 | +100.0% | 2.24% | – |
| VINC | VINCERX PHARMA INC | $10,502,000 | -37.0% | 1,030,634 | 0.0% | 2.11% | -39.0% | |
| CHRS | COHERUS BIOSCIENCES INC | $10,374,000 | -0.7% | 650,000 | 0.0% | 2.09% | -3.8% | |
| BLU | New | BELLUS HEALTH INC NEW | $9,660,000 | – | 1,200,000 | +100.0% | 1.94% | – |
| LEGN | New | LEGEND BIOTECH CORPsponsored adr | $9,322,000 | – | 200,000 | +100.0% | 1.88% | – |
| LIFE | ATYR PHARMA INC | $8,317,000 | -17.7% | 1,113,453 | 0.0% | 1.67% | -20.3% | |
| LPTX | LEAP THERAPEUTICS INC | $8,100,000 | -19.2% | 2,500,000 | 0.0% | 1.63% | -21.7% | |
| CRVS | Sell | CORVUS PHARMACEUTICALS INC | $7,475,000 | -58.8% | 3,101,709 | -17.3% | 1.50% | -60.1% |
| BCAB | New | BIOATLA INC | $5,848,000 | – | 297,914 | +100.0% | 1.18% | – |
| BGNE | New | BEIGENE LTDsponsored adr | $5,419,000 | – | 20,000 | +100.0% | 1.09% | – |
| RDUS | New | RADIUS HEALTH INC | $5,286,000 | – | 763,888 | +100.0% | 1.06% | – |
| GNFT | New | GENFIT S Aads | $5,280,000 | – | 1,055,994 | +100.0% | 1.06% | – |
| TANGO THERAPEUTICS INC | $5,128,000 | -15.4% | 468,750 | 0.0% | 1.03% | -18.0% | ||
| RVPH | REVIVA PHARMACEUTCLS HLDGS I | $3,468,000 | -29.0% | 1,200,000 | 0.0% | 0.70% | -31.3% | |
| CALT | New | CALLIDITAS THERAPEUTICS ABsponsored adr | $2,476,000 | – | 100,000 | +100.0% | 0.50% | – |
| ASLN | Buy | ASLAN PHARMACEUTICALS LTDads | $2,302,000 | +32.6% | 2,054,925 | +110.7% | 0.46% | +28.6% |
| EQ | EQUILLIUM INC | $2,262,000 | -44.7% | 600,000 | 0.0% | 0.46% | -46.5% | |
| RLMD | Sell | RELMADA THERAPEUTICS INC | $1,332,000 | -49.2% | 59,122 | -40.9% | 0.27% | -50.7% |
| CTMX | New | CYTOMX THERAPEUTICS INC | $660,000 | – | 152,345 | +100.0% | 0.13% | – |
| NXTC | Exit | NEXTCURE INC | $0 | – | -300,000 | -100.0% | -0.42% | – |
| APVO | Exit | APTEVO THERAPEUTICS INC | $0 | – | -1,760,000 | -100.0% | -5.64% | – |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2022-02-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| HERON THERAPEUTICS INC | 37 | Q3 2023 | 55.0% |
| LA JOLLA PHARMACEUTICAL CO | 34 | Q2 2022 | 37.1% |
| ROCKET PHARMACEUTICALS INC | 20 | Q3 2023 | 31.6% |
| BIOMARIN PHARMACEUTICAL INC | 18 | Q3 2017 | 12.1% |
| ODONATE THERAPEUTICS INC | 17 | Q4 2021 | 69.8% |
| ANAPTYSBIO INC | 16 | Q3 2023 | 18.4% |
| COHERUS BIOSCIENCES INC | 15 | Q3 2023 | 2.7% |
| EQUILLIUM INC | 13 | Q3 2023 | 1.2% |
| RELMADA THERAPEUTICS INC | 12 | Q4 2022 | 6.2% |
| MIRATI THERAPEUTICS INC | 11 | Q3 2023 | 10.9% |
View TANG CAPITAL MANAGEMENT LLC's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| 4 | 2024-02-14 |
| 4 | 2024-02-02 |
| 4 | 2023-12-18 |
| 13F-HR | 2023-11-14 |
| 4 | 2023-10-13 |
| 13F-HR | 2023-08-14 |
| 3 | 2023-06-01 |
| 4 | 2023-06-01 |
| 4 | 2023-05-30 |
View TANG CAPITAL MANAGEMENT LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.